NETRF funds $3.5 million in research to advance neuroendocrine tumor treatment

(Neuroendocrine Tumor Research Foundation) The Neuroendocrine Tumor Research Foundation (NETRF), Boston, MA, today announced $3.5 million in neuroendocrine tumor (NET) research grants to fund 12 projects around the world in pursuit of more precise treatments for this uncommon cancer affecting an estimated 171,000 Americans.